Evidence map›Paper›PMID 17362524›Full record

ReviewRetrovirology2007

Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Nicolas Gillet, Arnaud Florins, Mathieu Boxus, Catherine Burteau, Annamaria Nigro, Fabian Vandermeers, Hervé Balon, Amel-Baya Bouzar, Julien Defoiche, Arsène Burny and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Retrovirology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 1 synthesis or guideline pooled it, 398 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Exhausted CD4Frontiers in immunology · 2026
    Article
  18. Review
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Nicolas GilletMolecular and Cellular Biology, Faculté Universitaire des Sciences Agronomiques, Gembloux, Belgium. gillet.n@fsagx.ac.be
Arnaud Florins
Mathieu Boxus
Catherine Burteau
Annamaria Nigro
Fabian Vandermeers
Hervé Balon
Amel-Baya Bouzar
Julien Defoiche
Arsène Burny
Michal Reichert
Richard Kettmann
Luc Willems
Gembloux Agro-Bio Tech · BEFund for Scientific Research · BENational Veterinary Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine leukemia virus (BLV), belongs to the deltaretrovirus genus which also includes the related human T-lymphotropic virus type 1 (HTLV-1). This review summarizes current knowledge of this viral system, which is important as a model for leukemogenesis. Recently, the BLV model has also cast light onto novel prospects for therapies of HTLV induced diseases, for which no satisfactory treatment exists so far.

Indexed as

Disease Models, AnimalAnimalsAnti-Retroviral AgentsB-LymphocytesCattleCytokinesEnzootic Bovine LeukosisHumansHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellLeukemia Virus, BovineLeukocytes, MononuclearSheepSheep DiseasesViral ProteinsAnti-Retroviral AgentsCytokinesViral Proteins

Identifiers

PMID17362524
PMCPMC1839114
OpenAlexW2145594887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.